4//SEC Filing
Knight Robert Douglas 4
Accession 0001209191-22-023747
CIK 0001538210other
Filed
Apr 6, 8:00 PM ET
Accepted
Apr 7, 7:13 PM ET
Size
5.4 KB
Accession
0001209191-22-023747
Insider Transaction Report
Form 4
NexImmune, Inc.NEXI
Knight Robert Douglas
Chief Medical Officer
Transactions
- Award
Stock Options (Right to Buy)
2022-04-05+48,000→ 48,000 totalExercise: $4.22Exp: 2032-04-04→ Common Stock (48,000 underlying)
Footnotes (1)
- [F1]25% of this option shall vest and become exercisable on April 5, 2023, with the remainder vesting in 36 equal monthly installments thereafter, subject to Mr. Knight's continued service to the corporation on each vesting date.
Documents
Issuer
NexImmune, Inc.
CIK 0001538210
Entity typeother
Related Parties
1- filerCIK 0001844747
Filing Metadata
- Form type
- 4
- Filed
- Apr 6, 8:00 PM ET
- Accepted
- Apr 7, 7:13 PM ET
- Size
- 5.4 KB